Results 21 to 30 of about 5,270 (249)

Acute lymphoblastic leukemia and gingival enlargement – a case report

open access: yesHIV & AIDS Review. International Journal of HIV-Related Problems, 2021
Gingival enlargement is caused by various factors such as inflammation, medications and malignant diseases. Acute leukemic enlargement is commonly seen in children.
S. Gayathri   +3 more
doaj   +1 more source

An ounce of protection is worth a pound of cure: Periodontal management of Phenyto-in Induced Gingival Enlargement

open access: yesJournal of Clinical and Biomedical Sciences, 2019
Gingival enlargement (GE) is a condition of apprehension for both the patient and the doctor. GE can be due to inflammatory, idiopathic or drug induced. Drug induced gingival enlargement (DIGE) is an undesirable side effect resulting from intake
Deepa C
doaj   +1 more source

Keberhasilan terapi fase inisial periodontal pada gingival enlargement pasien anak dengan hidrosefalus

The success of initial periodontal therapy phase in gingival enlargement paediatric patient with hydrocephalus

open access: yesJurnal Kedokteran Gigi Universitas Padjadjaran, 2020
Pendahuluan: gingival enlargement umumnya terjadi akibat inflamasi kronis yang disebabkan oleh faktor lokal, seperti induksi plak pada gingiva dan faktor sistemik seperti  pengaruh hormon dan obat-obatan sistemik tertentu.
Nunung Rusminah   +2 more
doaj   +1 more source

Idiopathic gingival fibromatosis with periodontitis: A rare case report and literature

open access: yesJournal of Medical Sciences, 2021
Idiopathic gingival fibromatosis (IGF) is a hereditary condition with esthetic, functional, and periodontal impairment in patients. It is slowly progressive in nature.
Shivani Sachdeva   +2 more
doaj   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Phenytoin-induced gingival enlargement [PDF]

open access: yesBMJ Case Reports, 2014
Gingival overgrowth occurs as a side effect of some systemic medications. It is now well established that phenytoin is one such agent. It has multiple therapeutic indications ranging from convulsive disorders and neuralgias to cardiac arrhythmia. The incidence rate of phenytoin-induced gingival overgrowth ranges from 3% to 93%, but 50% of patients on ...
Lisa Neelathil, Chacko, Sathish, Abraham
openaire   +2 more sources

Hereditary Gingival Fibromatosis: Report of Family Pedigree of Three Generations [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Gingival enlargement or gingival overgrowth can be defined as increase in the size of gingiva, caused due to a variety of etiological factors. One of the causes of gingival enlargement is hereditary gingival fibromatosis, which is a genetic disorder ...
JAIDEEP MAHENDRA   +3 more
doaj   +1 more source

Gingival enlargement as oral manifestation in acute myeloid leukemia patient

open access: yesDental Journal, 2017
Background: Acute myeloid leukemia (AML) is a bone marrow cancer, a malignant disease that triggering the cells develops into different types of blood cells.
Sandra Olivia Kuswandani   +2 more
doaj   +1 more source

Low dose amlodipine-induced gingival enlargement: A clinical case series

open access: yesContemporary Clinical Dentistry, 2015
Gingival enlargement sometimes has an adverse effect of certain systemic drugs such as the use of anticonvulsants, phenytoin, antihypertensive, calcium channel blockers and immunosuppressant, cyclosporine.
Amitandra Kumar Tripathi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy